Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W J Greenlee

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1982
Phosphorus-containing inhibitors of angiotensin-converting enzymeE D Thorsett, E E Harris, E R Peterson, et al.
Journal of Medicinal Chemistry|August 1, 1989
(3-Amino-2-oxoalkyl)phosphonic acids and their analogues as novel inhibitors of D-alanine:D-alanine ligaseP K Chakravarty, W J Greenlee, W H Parsons, et al.
Bioorganic & Medicinal Chemistry Letters|July 11, 2006
Tetrahydroisoquinolines as MCH-R1 antagonistsT K Sasikumar, L Qiang, W-L Wu, et al.
Journal of Medicinal Chemistry|July 24, 1992
Inhibitors of human renin with C-termini derived from amides and esters of alpha-mercaptoalkanoic acidsW T Ashton, C L Cantone, R L Tolman, et al.
Journal of Medicinal Chemistry|September 1, 1991
Design and synthesis of P2-P1'-linked macrocyclic human renin inhibitorsA E Weber, T A Halgren, J J Doyle, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1992
In vitro pharmacology of L-158,809, a new highly potent and selective angiotensin II receptor antagonistR S Chang, P K Siegl, B V Clineschmidt, et al.
Biochemistry|June 27, 1989
Design of a selective insulin receptor tyrosine kinase inhibitor and its effect on glucose uptake and metabolism in intact cellsR Saperstein, P P Vicario, H V Strout, et al.
Molecular Pharmacology|February 1, 1997
Dual agonistic and antagonistic property of nonpeptide angiotensin AT1 ligands: susceptibility to receptor mutationsS Perlman, C M Costa-Neto, A A Miyakawa, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1992
In vivo pharmacology of L-158,809, a new highly potent and selective nonpeptide angiotensin II receptor antagonistP K Siegl, R S Chang, N B Mantlo, et al.
Journal of Medicinal Chemistry|March 6, 1992
Synthesis and use of 3-amino-4-phenyl-2-piperidones and 4-amino-2-benzazepin-3-ones as conformationally restricted phenylalanine isosteres in renin inhibitorsS E de Laszlo, B L Bush, J J Doyle, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1982
Phosphorus-containing inhibitors of angiotensin-converting enzymeE D Thorsett, E E Harris, E R Peterson, et al.
Journal of Medicinal Chemistry|August 1, 1989
(3-Amino-2-oxoalkyl)phosphonic acids and their analogues as novel inhibitors of D-alanine:D-alanine ligaseP K Chakravarty, W J Greenlee, W H Parsons, et al.
Bioorganic & Medicinal Chemistry Letters|July 11, 2006
Tetrahydroisoquinolines as MCH-R1 antagonistsT K Sasikumar, L Qiang, W-L Wu, et al.
Journal of Medicinal Chemistry|July 24, 1992
Inhibitors of human renin with C-termini derived from amides and esters of alpha-mercaptoalkanoic acidsW T Ashton, C L Cantone, R L Tolman, et al.
Journal of Medicinal Chemistry|September 1, 1991
Design and synthesis of P2-P1'-linked macrocyclic human renin inhibitorsA E Weber, T A Halgren, J J Doyle, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1992
In vitro pharmacology of L-158,809, a new highly potent and selective angiotensin II receptor antagonistR S Chang, P K Siegl, B V Clineschmidt, et al.
Biochemistry|June 27, 1989
Design of a selective insulin receptor tyrosine kinase inhibitor and its effect on glucose uptake and metabolism in intact cellsR Saperstein, P P Vicario, H V Strout, et al.
Molecular Pharmacology|February 1, 1997
Dual agonistic and antagonistic property of nonpeptide angiotensin AT1 ligands: susceptibility to receptor mutationsS Perlman, C M Costa-Neto, A A Miyakawa, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1992
In vivo pharmacology of L-158,809, a new highly potent and selective nonpeptide angiotensin II receptor antagonistP K Siegl, R S Chang, N B Mantlo, et al.
Journal of Medicinal Chemistry|March 6, 1992
Synthesis and use of 3-amino-4-phenyl-2-piperidones and 4-amino-2-benzazepin-3-ones as conformationally restricted phenylalanine isosteres in renin inhibitorsS E de Laszlo, B L Bush, J J Doyle, et al.
Pageof 4